期刊文献+

外周血中TREC水平与HIV感染疾病进展的关系 被引量:2

Relationship between TREC levels in peripheral blood and progression of HIV infection
原文传递
导出
摘要 目的建立T细胞受体脱氧核糖核酸重排删除环(TREC)的检测方法,并分析TREC与艾滋病疾病进展之间的关系。方法利用实时定量聚合酶链反应(PCR)技术,建立检测TREC水平的方法,并对未治疗病人及治疗后免疫重建成功与失败病人外周血中TREC水平进行分析。结果85例未治疗的艾滋病病毒(HIV)感染者,CD4^+T淋巴细胞(简称CD4细胞)>350个/μL病人的TREC水平(32.5±7.65)高于CD4细胞在200~350个/μL的病人(19.9±6.26),而CD4细胞<200个/μL病人的TREC水平最低(9.5±1.87);免疫重建成功病人的TREC水平(28.2±10.1)远高于免疫重建失败病人(10±5.1)。结论未治疗的HIV感染者,随着CD4细胞水平的增加,外周血中TREC细胞的水平也明显增加;免疫重建成功病人外周血中TREC的水平明显高于免疫重建失败的病人。 Objective To establish a method for detection of TREC and to analyze the relationship between the levels of TREC in peripheral blood and the progression of HIV infection.Methods We established real-time PCR method to detect TREC levels in peripheral blood of untreated patients and patients with successful or failed immune reconstitution after treatment and compared the differences of TREC between different patients.Results In untreated patients with the increased CD4^+,TREC level was significantly increasing.The level of TREC was significantly higher in the successful immune reconstitution patients than that in the patients of immune reconstitution failure.Conclusion The level of TREC cells in peripheral blood increases significantly with the increase of CD4^+cell level in untreated patients.The level of TREC in peripheral blood of successful immune reconstruction patients is significantly higher than that of patients with failed immune reconstruction.
作者 张海红 姜太一 何焱玲 ZHANG Haihong;JIANG Taiyi;HEYanling(Beijing Huairou Hospital,Beijing 101400,China;Beijing You’an Hospital,Capital Medical University,Beijing 100069;Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2019年第6期569-572,共4页 Chinese Journal of Aids & STD
基金 国家科技重大专项(2015ZX10004801-002-002) 国家自然科学基金(81371803,81571973)~~
  • 相关文献

参考文献1

二级参考文献62

  • 1Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease[J]. Science, 1997,277(5322): 112-116.
  • 2Guihot A, Bourgarit A, Carcelain G, et al. Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus[J]. Trends Immunol,2011,32(3): 131-137.
  • 3Autran B, Carcelaint G, Li TS, et al. Restoration of the immune system with anti-retroviral therapy[J]. Immunol Lett,1999,66(1- 3):207-211.
  • 4Piketty C, Castiel P, Belec L, et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease[J]. AIDS,1998,12(7):745-750.
  • 5Grabar S, Le MV, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy[J]. Ann Intern Med,2000,133(6):401-410.
  • 6Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV cohort study[J]. Arch Intern Med,2003,163(18):2187-2195.
  • 7Marziali M, De Santis W, Carello R, et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART[J]. AIDS,2006,20(16):2033-2041.
  • 8Erikstrup C, Kronborg G, Lohse N, et al. T-cell dysfunction in HIV-l-infected patients with impaired recovery of CD4 cells despite suppression of viral replication[J]. J Aequir Immune Defic Syndr,2010,53(3):303 -310.
  • 9Li T, Wu N, Dai Y, et al. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy[J]. Clin Infect Dis,2011,53(9):944-951.
  • 10Pacheco YM, Jarrin I, Del AJ, et al. Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAART[J]. Curr HIV Res,2009,7(6):612-619.

共引文献23

同被引文献35

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部